ArticleiScience2023

NDC80 status pinpoints mitotic kinase inhibitors as emerging therapeutic options in clear cell renal cell carcinoma.

Cheng Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.